Vnitr Lek 2006, 52(6):552-555

Katetrizační ablace komorových tachykardií provázejících strukturní onemocnění srdce: editorial

J. Kautzner
Klinika kardiologie Institutu klinické a experimentální medicíny, Praha, přednosta prof. MUDr. Josef Kautzner, CSc., FESC

Received: February 2, 2006; Published: June 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kautzner J. Katetrizační ablace komorových tachykardií provázejících strukturní onemocnění srdce: editorial. Vnitr Lek. 2006;52(6):552-555.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Josephson ME. Recurrent ventricular tachycardia. In: Josephson ME (ed). Clinical Cardiac Electrophysiology: Techniques and Interpretation. 3rd ed. Philadelphia: Lippincott Williams & Wilkins 2002: 425-610.
    2. Kautzner J. Komorové arytmie. In: Aschermann M (ed). Kardiologie. Praha: Galén 2004: 1157-1172.
    3. Wu J, Wu J, Zipes DP. Mechanisms of initiation of ventricular tachyarrhythmias In: Zipes DP, Jaliffe J (eds). Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Saunders 2004: 380-389. Go to original source...
    4. Fiala M, Chovančík J, Neuwirth R et al. Setrvalá monomorfní komorová tachykardie u pacientů se strukturálním postižením srdce: různé arytmogenní substráty, různé možnosti paliativní nebo kurativní léčby katetrovou ablací v éře trojrozměrného mapování. Vnitř Lék 2006; 52: 577-589. Go to PubMed...
    5. de Bakker JMT, Stein M, van Rijen HVM. Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation. Heart Rhythm 2005; 2: 777-779. Go to original source... Go to PubMed...
    6. Setser R, Bexell D, O'Donnel TP et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2001; 18: 434-441. Go to original source... Go to PubMed...
    7. Marchlinski FE, Callans DJ, Gottlieb CD et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000; 101: 1288-1296. Go to original source... Go to PubMed...
    8. Hsia HH. Substrate mapping: the historical perspective and current status. J Cardiovasc Electrophysiol 2003; 14: 530-532. Go to original source... Go to PubMed...
    9. Reddy VY, Neuzil P, Taborsky M et al. Short-term results of substrate mapping and rediofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol 2003; 41: 2228-2236. Go to original source... Go to PubMed...
    10. Kottkamp H, Wetzel U, Schirdewahn P et al. Catheter ablation of ventricular tachycardia in remote myocardial infarction: substrate description guiding placement of individual linear lesions targeting noninducibility. J Cardiovasc Electrophysiol 2003; 14: 675-681. Go to original source... Go to PubMed...
    11. Stevenson WG, Khan H, Sager P et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88: 1647-1670. Go to original source... Go to PubMed...
    12. Kautzner J, Čihák R, Peichl P et al. Catheter ablation of ventricular tachycardia following myocardial infarction using a 3-D electroanatomical mapping. PACE 2003; 26 [pt II]: 342-347. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.